Congratulations to Dr. Lou Siminovitch for receiving the 2018 UHN Global Impact Award for his outstanding contributions to medical research both nationally and globally.
Dr. Siminovitch was a founding member of the IMS, and held an active faculty appointment until 2011. He was also a long standing member of the IMS executive committee. In 1995 the IMS created the Siminovitch-Salter award outstanding scholarly contributions by a PhD student to highlight Dr. Simovitch’s long association and friendship with a superb MD/scientist, Dr. Robert Salter, and to honour their mutual respect for research excellence.
Dr. Siminovitch, joined the Ontario Cancer Institute (OCI), the research institute of Princess Margaret Hospital, in 1956, going on to become its Director. He was cited by nominators for a range of impacts throughout his career; from “seminal discoveries” and “visionary scientific leadership” to the establishment of university research institutes, mentorship and public policy development at the provincial and national level.
“Professor Siminovitch has had a massive and transformative effect on biomedical research in Toronto, Canada and internationally,” Dr. Peter St George-Hyslop, University Professor, Department of Medicine, University of Toronto, and Professor of Experimental Neuroscience, University of Cambridge, wrote in a nomination letter.
Dr. Siminovitch also held key positions at the Hospital for Sick Children Research Institute, the Samuel Lunenfeld Institute at Mount Sinai Hospital and various departments at the University of Toronto. He was inducted into the Canadian Medical Hall of Fame in 1997.
Awarded since 2004, the UHN Global Impact Award recognizes the outstanding contributions of University Health Network staff, such as Dr. Siminovitch, who have revolutionized health and healthcare nationally and around the world.